Compare SBH & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SBH | CMPS |
|---|---|---|
| Founded | 1964 | 2020 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 2006 | 2020 |
| Metric | SBH | CMPS |
|---|---|---|
| Price | $12.50 | $10.87 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 8 |
| Target Price | $17.25 | ★ $25.38 |
| AVG Volume (30 Days) | 1.6M | ★ 4.3M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.17 | N/A |
| EPS | ★ 0.88 | N/A |
| Revenue | ★ $3,701,424,000.00 | N/A |
| Revenue This Year | $2.20 | N/A |
| Revenue Next Year | $1.82 | N/A |
| P/E Ratio | $13.71 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.45 | $2.25 |
| 52 Week High | $17.92 | $11.65 |
| Indicator | SBH | CMPS |
|---|---|---|
| Relative Strength Index (RSI) | 40.85 | 63.95 |
| Support Level | N/A | $5.95 |
| Resistance Level | $15.75 | N/A |
| Average True Range (ATR) | 0.63 | 0.71 |
| MACD | -0.14 | 0.01 |
| Stochastic Oscillator | 34.22 | 72.66 |
Sally Beauty Holdings Inc is a professional beauty-products retailer based in the United States. The company operates throughout the United States, Puerto Rico, the United Kingdom, Belgium, Canada, Chile, Mexico, Peru, France, Ireland, Spain, Germany, Netherlands, and other geographical regions. The company operates through two business segments: Sally Beauty Supply and Beauty Systems Group. The products offered by the company include hair color and care, hair dryers and hair-styling appliances, nail care, skin care, and others.
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.